Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1402, Issue 2, 1998, Pages 197-208

  Onuma, Hiroshi ^a   Makino, Hideichi ^a   Osawa, Haruhiko ^a   Suzuki, Yoshifumi ^b   Taira, Masato ^b   Kanatsuka, Azuma ^b   Saito, Yasushi ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclic AMP phosphodiesterase kinase; Insulin; MAP kinase; P70(S6K); Phosphatidylinositol 3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIC AMP PHOSPHODIESTERASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; RIBOSOME PROTEIN; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA;

EID: 0032571422     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00003-2     Document Type: Article

References (56)

1. Kono T., Barham F.W. Effects of insulin on the levels adenosine 3′:5′-monophosphate and lipolysis in isolated rat epididymal fat cells. J. Biol. Chem. 248:1973;7417-7426.
2. Makino H., Suzuki T., Kajinuma H., Yamazaki M., Ito H., Yoshida S. The role of insulin-sensitive phosphodiesterase in insulin action. Ad. Second Messenger Phosphoprotein Res. 25:1992;185-189.
3. Elks M.L., Manganiello V.C. Selective effects of phosphodiesterase inhibitors on different phosphodiesterase, adenosine 3′,5′-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Endocrinology. 115:1984;1262-1268.
4. Manganiello V., Vaughan M. An effect of insulin on cyclic adenosine 3′:5′-monophosphate phosphodiesterase activity in fat cells. J. Biol. Chem. 248:1973;7164-7170.
5. Loten E.G., Sneyd I.G.T. An effect of insulin on adipose-tissue adenosine 3′,5′-cyclic monophosphate phosphodiesterase. Biochem. J. 120:1970;187-193.
6. Kono T., Robinson F.W., Sarver J.A. Insulin-sensitive phosphodiesterase: its localization, hormonal stimulation, and oxidative stabilization. J. Biol. Chem. 250:1975;7826-7835.
7. Zinman B., Hollenberg C.H. Effect of insulin and lipolytic agents on rat adipocyte low Km cyclic adenosine 3′:5′-monophosphate phosphodiesterase. J. Biol. Chem. 249:1974;2182-2187.
8. Pawlson L.G., Lovell-Smith C.J., Manganiello V.C., Vaughan M. Effect of epinephrine, adrenocorticotrophic hormone, and theophylline on adenosine 3′,5′-monophosphate phosphodiesterase activity in fat cells. Proc. Natl. Acad. Sci. U.S.A. 71:1974;1639-1642.
9. Makino H., Kono T. Characterization of insulin-sensitive phosphodiesterase in fat cells. J. Biol. Chem. 255:1980;7850-7854.
10. Degerman E., Smith C.J., Tornqvist H., Vasta V., Belfrage P., Manganiello V.C. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87:1990;533-537.
11. Rahn T., Ronnstrand L., Leroy M.J., Wernstedt C., Tornqvist H., Manganiello V.C., Belfrage P., Degerman E. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J. Biol. Chem. 271:1996;11575-11580.
12. Shibata H., Robinson F.W., Soderling T.R., Kono T. Effects of okadaic acid on insulin-sensitive cAMP phosphodiesterase in rat adipocytes; evidence that insulin may stimulate the enzyme by phosphorylation. J. Biol. Chem. 266:1991;17948-17953.
13. Smith C.J., Shibata H., Manganiello V., Berfrage P., Kono T. Phosphorylation and activation of hormone-sensitive cAMP phosphodiesterase (cGI PDE) by cytosolic extracts of insulin-treated rat adipocytes. FASEB J. 6:1992;A340.
14. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:1994;3568-3573.
15. Rahn T., Ridderståle M., Tornqvist H., Manganiello V., Fredrikson G., Belfrage P., Degerman E. Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes: studies using the selective inhibitor wortmannin. FEBS Lett. 350:1994;314-318.
16. Cross D.A.E., Alessi D.R., Vandenheede J.R., McDowell H.E., Hundal H.S., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303:1994;21-26.
17. Standaert M., Bandyopadhyay G., Farese R.V. Studies with wortmannin suggest a role for phosphatidylinositol 3-kinase in the activation of glycogen synthase and mitogen-activated protein kinase by insulin in rat adipocytes: comparison of insulin and protein kinase C modulators. Biochem. Biophys. Res. Commun. 209:1995;1082-1088.
18. Welsh G.I., Foulstone E.J., Young S.W., Tavaré J.M., Proud C.G. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem. J. 303:1994;15-20.
19. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:1994;4902-4911.
20. Taira M., Hockman S.C., Calvo J.C., Taira M., Belfrage P., Manganiello V.C. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem. 268:1993;18573-18579.
21. mpk, meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:1991;15180-15184.
22. Rodbell M. Metabolism of isolated fat cells. J. Biol. Chem. 239:1964;375-380.
23. Ferby I.M., Waga I., Sakanaka C., Kume K., Shimizu T. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J. Biol. Chem. 269:1994;30485-30488.
24. Lin T.-A., Lawrence J.C.J. Activation of ribosomal protein S6 kinases does not increase glycogen synthesis or glucose transport in rat adipocytes. J. Biol. Chem. 269:1994;21255-21261.
25. Shibata H., Kono T. Stimulation of the insulin-sensitive cAMP phosphodiesterase by an ATP-dependent soluble factor from insulin-treated rat adipocytes. Biochem. Biophys. Res. Commun. 167:1990;614-620.
26. Shibata H., Kono T. Cell-free stimulation of the insulin-sensitive cAMP phosphodiesterase by the joint actions of ATP and the soluble fraction from insulin-treated rat liver. Biochem. Biophys. Res. Commun. 170:1990;533-539.
27. Dudley D.D., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7686-7689.
28. Moule S.K., Edgell N.J., Welsh G.I., Diggle T.A., Foulstone E.J., Heesom K.J., Proud C.G., Denton R.M. Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. Biochem. J. 311:1995;595-601.
29. Kuribayashi N., Makino H., Kanatsuka A., Yoshida S. Effect of somatomedin C on insulin-sensitive phosphodiesterase in rat fat cells. Metabolism. 37:1988;635-639.
30. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 370:1994;71-75.
31. Yamamoto-Honda R., Tobe K., Kaburagi Y., Ueki K., Asai S., Yachi M., Shirouzu M., Yodoi J., Akanuma Y., Yokoyama S., Yazaki Y., Kadowaki T. Upstream mechanism of glycogen synthase activation by insulin and insulin-like growth factor-I. J. Biol. Chem. 270:1995;2729-2734.
32. Price D.J., Grove J.R., Calvo V., Avruch J., Bierer B.E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 257:1992;973-977.
33. Sommercorn J., Mulligan J.A., Lozeman F.J., Krebs E.G. Activation of casein kinase II in response to insulin and to epidermal growth factor. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8834-8838.
34. Kawamoto S., Hidaka H. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem. Biophys. Res. Commun. 125:1984;258-264.
35. Stokoe D., Campbell D.G., Nakielny S., Hidaka H., Leevers S.J., Marshall C., Cohen P. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11:1992;3985-3994.
36. Dent P., Lavoinne A., Nakielny S., Caudwell F.B., Watt P., Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature. 348:1990;302-308.
37. Chijiwa T., Hagiwara M., Hidaka H. A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloro-isoquinoline-8-sulfonamide and affinity purification of casein kinase I from bovine testis. J. Biol. Chem. 264:1989;4924-4927.
38. 2+/phospholipid-dependent protein kinase. J. Biol. Chem. 261:1986;15266-15272.
39. 2+-dependent cytosolic serine kinase in rat adipocytes. J. Biol. Chem. 262:1987;16677-16685.
40. Manganiello V.C., Murata T., Taira M., Belfrage P., Degerman E. Perspectives in biochemistry and biophysics. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys. 322:1995;1-13.
41. Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.-C., Tsubokawa M., Mason A., Seeburg P.H., Grunfeld C., Rosen O.M., Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 313:1985;756-761.
42. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J.-H., Masiarz F., Kan Y.W., Goldfine I.D., Roth R.A., Rutter W.J. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 40:1985;747-758.
43. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:1991;73-77.
44. White M.F., Kahn C.R. The insulin signaling system. J. Biol. Chem. 269:1994;1-4.
45. Denton R.M., Tavaré J.M. Does mitogen-activated-protein kinase have a role in insulin action: the cases for and against. Eur. J. Biochem. 227:1995;597-611.
46. Makino H., Manganiello V.C., Kono T. Roles of ATP in insulin actions. Annu. Rev. Physiol. 56:1994;273-295.
47. Kanai F., Ito K., Todaka M., Hayashi H., Kamohara S., Ishii K., Okada T., Hazeki O., Ui M., Ebina Y. Insulin-stimulated Glut4 translocation is relevant to the phosphorylation of IRS-1 and activity of PI3-kinase. Biochem. Biophys. Res. Commun. 195:1993;762-768.
48. Yeh J.-I., Gulve E.A., Rameh L., Birnbaum M.J. The effect of wortmannin on rat skeletal muscle; dissociation of signal pathways insulin- and contraction-activated hexose transport. J. Biol. Chem. 270:1995;2107-2111.
49. Sutherland C., O'Brien R.M., Granner D.K. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. J. Biol. Chem. 270:1995;15501-15506.
50. Sakaue H., Hara K., Noguchi T., Matozaki T., Kotani K., Ogawa W., Yonezawa K., Waterfield M.D., Kasuga M. Ras-dependent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary cells. J. Biol. Chem. 270:1995;11304-11309.
51. Moule S.K., Welsh G.I., Edgell N.J., Foulstone E.J., Proud C.G., Denton R.M. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and β-adrenergic agonist in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272:1997;7713-7719.
52. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (Ly294002). J. Biol. Chem. 269:1994;5241-5248.
53. Lasar D.F., Wiese R.J., Brady M.J., Mastick C.C., Waters S.B., Yamauchi K., Pessin J.E., Cuatrecasas P.C., Saltiel A.R. Mitogen-activated protein kinase inhibition dose not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270:1995;20801-20807.
54. Mollinedo F., Gajate C., Flores I. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid jurkat cells. J. Immunol. 153:1994;2457-2469.
55. 2 activity in Swiss 3T3 cells. J. Biol. Chem. 270:1995;25352-25355.
56. Brunn G.J., Williams J., Sabers C., Wiederrecht G., Lawrence J.C.J., Abraham R.T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:1996;5256-5267.